The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 08, 2015

Filed:

Oct. 28, 2013
Applicant:

Synecor Llc, Chapel Hill, NC (US);

Inventors:

Terrance J Ransbury, Chapel Hill, NC (US);

William E Sanders, Chapel Hill, NC (US);

Richard S Stack, Chapel Hill, NC (US);

Colleen Stack, Chapel Hill, NC (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61N 1/00 (2006.01); A61N 1/362 (2006.01); A61N 1/05 (2006.01); A61N 1/36 (2006.01); A61B 5/01 (2006.01); A61B 5/0215 (2006.01); A61B 5/024 (2006.01); A61M 25/00 (2006.01); A61M 25/01 (2006.01); A61M 25/04 (2006.01);
U.S. Cl.
CPC ...
A61N 1/3621 (2013.01); A61N 1/056 (2013.01); A61N 1/36114 (2013.01); A61B 5/01 (2013.01); A61B 5/024 (2013.01); A61B 5/0215 (2013.01); A61M 25/0074 (2013.01); A61M 25/0125 (2013.01); A61M 25/0147 (2013.01); A61M 25/04 (2013.01); A61M 2025/0175 (2013.01); A61N 1/057 (2013.01); A61N 1/3627 (2013.01);
Abstract

A neuromodulation system for treating acute heart failure syndromes includes a first catheter having a parasympathetic therapy element adapted for positioning within a first blood vessel such as a superior vena cava, and a second catheter sympathetic therapy element adapted for positioning with a second, different, blood vessel such as the pulmonary artery. The catheters comprise a system in which one of catheters is slidably disposed over the other of the catheters. The system may further be slidably disposed over a third elongate element such as a Swan-Ganz catheter positionable within a pulmonary artery, such that the Swan-Ganz may be used for monitoring parameters such as blood pressure and cardiac output during neuromodulation therapy. The parasympathetic therapy element is energized to deliver neuromodulation therapy to a parasympathetic nerve fiber such as a vagus nerve, while the sympathetic therapy element is energized to deliver neuromodulation therapy to a sympathetic nerve fiber such as a sympathetic cardiac nerve fiber. For treatment of acute heart failure syndromes, the neuromodulation therapy may be used to lower heart rate and increase cardiac inotropy.


Find Patent Forward Citations

Loading…